drugset / Trial / NCT05718037
Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
RandomizedSequentialQuadruple-blindPrevention
Summary
This is a phase I, randomized, observer-blinded study to evaluate the safety, tolerability, and immunogenicity of BV211(a herpes zoster vaccine) in Adult Volunteers.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2024-01-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E | Vaccine | 0.5 ml | Intramuscular |